• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hsp27 与磷酸化 Tau 的特异性结合减轻了异常 Tau 聚集诱导的病变。

Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.

机构信息

Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.

Department of Molecular and Cellular Pharmacology, University of Miami Miller School of Medicine, Miami, United States.

出版信息

Elife. 2022 Sep 1;11:e79898. doi: 10.7554/eLife.79898.

DOI:10.7554/eLife.79898
PMID:36048712
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9436411/
Abstract

Amyloid aggregation of phosphorylated Tau (pTau) into neurofibrillary tangles is closely associated with Alzheimer's disease (AD). Several molecular chaperones have been reported to bind Tau and impede its pathological aggregation. Recent findings of elevated levels of Hsp27 in the brains of patients with AD suggested its important role in pTau pathology. However, the molecular mechanism of Hsp27 in pTau aggregation remains poorly understood. Here, we show that Hsp27 partially co-localizes with pTau tangles in the brains of patients with AD. Notably, phosphorylation of Tau by microtubule affinity regulating kinase 2 (MARK2), dramatically enhances the binding affinity of Hsp27 to Tau. Moreover, Hsp27 efficiently prevents pTau fibrillation in vitro and mitigates neuropathology of pTau aggregation in a tauopathy model. Further mechanistic study reveals that Hsp27 employs its N-terminal domain to directly interact with multiple phosphorylation sites of pTau for specific binding. Our work provides the structural basis for the specific recognition of Hsp27 to pathogenic pTau, and highlights the important role of Hsp27 in preventing abnormal aggregation and pathology of pTau in AD.

摘要

磷酸化 Tau(pTau)的淀粉样聚集与阿尔茨海默病(AD)密切相关。已有报道称,几种分子伴侣可以结合 Tau 并阻止其病理性聚集。最近发现 AD 患者大脑中 HSP27 水平升高,表明其在 pTau 病理中的重要作用。然而,HSP27 在 pTau 聚集中的分子机制仍知之甚少。本研究显示,Hsp27 部分与 AD 患者大脑中的 pTau 缠结共定位。值得注意的是,微管亲和调节激酶 2(MARK2)对 Tau 的磷酸化,显著增强了 Hsp27 与 Tau 的结合亲和力。此外,Hsp27 可有效防止 Tau 在体外纤维形成,并减轻 Tau 聚集病变模型中的神经病理学损伤。进一步的机制研究表明,Hsp27 利用其 N 端结构域直接与 pTau 的多个磷酸化位点相互作用,实现特异性结合。本研究为 Hsp27 对致病性 pTau 的特异性识别提供了结构基础,并强调了 Hsp27 在预防 AD 中 pTau 异常聚集和病理损伤中的重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/3ddafeb9f908/elife-79898-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/d2b580955592/elife-79898-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/418cd77fc3d4/elife-79898-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/e3b15d20f3ee/elife-79898-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/3f56117f3068/elife-79898-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/54e4b47eabd1/elife-79898-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/13a8abb62450/elife-79898-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/1d4e4e8112a7/elife-79898-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/add6a2c84f86/elife-79898-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/0c19517eb661/elife-79898-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/0f7335696326/elife-79898-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/3ddafeb9f908/elife-79898-sa2-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/d2b580955592/elife-79898-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/418cd77fc3d4/elife-79898-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/e3b15d20f3ee/elife-79898-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/3f56117f3068/elife-79898-fig3-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/54e4b47eabd1/elife-79898-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/13a8abb62450/elife-79898-fig4-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/1d4e4e8112a7/elife-79898-fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/add6a2c84f86/elife-79898-fig5-figsupp1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/0c19517eb661/elife-79898-fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/0f7335696326/elife-79898-fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ee88/9436411/3ddafeb9f908/elife-79898-sa2-fig1.jpg

相似文献

1
Specific binding of Hsp27 and phosphorylated Tau mitigates abnormal Tau aggregation-induced pathology.Hsp27 与磷酸化 Tau 的特异性结合减轻了异常 Tau 聚集诱导的病变。
Elife. 2022 Sep 1;11:e79898. doi: 10.7554/eLife.79898.
2
Nicotinamide mononucleotide adenylyltransferase uses its NAD substrate-binding site to chaperone phosphorylated Tau.烟酰胺单核苷酸腺苷酰转移酶利用其 NAD 底物结合位点来伴侣磷酸化 Tau。
Elife. 2020 Apr 6;9:e51859. doi: 10.7554/eLife.51859.
3
Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.小热休克蛋白Hsp27或αB-晶状体蛋白与神经原纤维缠结的蛋白质成分:tau蛋白和神经丝。
J Neurosci Res. 2008 May 1;86(6):1343-52. doi: 10.1002/jnr.21589.
4
Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.tau蛋白磷酸化、分子伴侣与泛素E3连接酶:在阿尔茨海默病中的临床相关性
J Alzheimers Dis. 2015;43(2):341-61. doi: 10.3233/JAD-140933.
5
Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.Hsp90 通过阿尔茨海默病中的共伴侣复合物调节 tau 病理学。
Prog Neurobiol. 2011 Jan;93(1):99-110. doi: 10.1016/j.pneurobio.2010.10.006. Epub 2010 Nov 5.
6
Cellular factors modulating the mechanism of tau protein aggregation.调节tau蛋白聚集机制的细胞因子。
Cell Mol Life Sci. 2015 May;72(10):1863-79. doi: 10.1007/s00018-015-1839-9. Epub 2015 Feb 11.
7
Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.tau 丝氨酸 208 位磷酸化促进聚集,并揭示阿尔茨海默病和其他 tau 病中的神经病理学多样性。
Acta Neuropathol Commun. 2020 Jun 22;8(1):88. doi: 10.1186/s40478-020-00967-w.
8
Release of a disordered domain enhances HspB1 chaperone activity toward tau.无序结构域的释放增强了 HspB1 对 tau 的分子伴侣活性。
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):2923-2929. doi: 10.1073/pnas.1915099117. Epub 2020 Jan 23.
9
Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.小胶质细胞的激活发生在神经元特异性 P301S tau 病变小鼠模型中磷酸化 tau 聚集之后。
Neurobiol Aging. 2020 May;89:89-98. doi: 10.1016/j.neurobiolaging.2020.01.003. Epub 2020 Jan 10.
10
αB-crystallin and HSP27 in glial cells in tauopathies.tau蛋白病中神经胶质细胞中的αB-晶状体蛋白和热休克蛋白27
Neuropathology. 2014 Dec;34(6):517-26. doi: 10.1111/neup.12134. Epub 2014 Jul 2.

引用本文的文献

1
CDK5-mediated hyperphosphorylation of Tau217 impairs neuronal synaptic structure and exacerbates cognitive impairment in Alzheimer's disease.细胞周期蛋白依赖性激酶5介导的Tau217过度磷酸化会损害神经元突触结构,并加重阿尔茨海默病的认知障碍。
Transl Psychiatry. 2025 Aug 21;15(1):302. doi: 10.1038/s41398-025-03551-9.
2
Identification of Alzheimer's disease biomarkers and their immune function characterization.阿尔茨海默病生物标志物的鉴定及其免疫功能特征分析。
Arch Med Sci. 2024 Jun 7;21(1):233-257. doi: 10.5114/aoms/188721. eCollection 2025.
3
Capturing the Conformational Heterogeneity of HSPB1 Chaperone Oligomers at Atomic Resolution.

本文引用的文献

1
Mechanistic basis for receptor-mediated pathological α-synuclein fibril cell-to-cell transmission in Parkinson's disease.帕金森病中受体介导的病理性α-突触核蛋白纤维细胞间传递的机制基础。
Proc Natl Acad Sci U S A. 2021 Jun 29;118(26). doi: 10.1073/pnas.2011196118.
2
"Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies.“不要忽视 Tau”:阿尔茨海默病和其他 Tau 病中针对 Tau 磷酸化的临床生物标志物和治疗方法的最新进展。
Mol Neurodegener. 2021 Jun 5;16(1):37. doi: 10.1186/s13024-021-00460-5.
3
Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer's Disease.
以原子分辨率捕捉热休克蛋白B1伴侣寡聚体的构象异质性。
J Am Chem Soc. 2025 May 7;147(18):15181-15194. doi: 10.1021/jacs.4c18668. Epub 2025 Mar 27.
4
Chaperones as Potential Pharmacological Targets for Treating Protein Aggregation Illness.伴侣蛋白作为治疗蛋白质聚集疾病的潜在药理学靶点
Curr Protein Pept Sci. 2025 Jan 27. doi: 10.2174/0113892037338028241230092414.
5
Inducers and modulators of protein aggregation in Alzheimer's disease - Critical tools for understanding the foundations of aggregate structures.阿尔茨海默病中蛋白质聚集的诱导剂和调节剂——理解聚集体结构基础的关键工具。
Neurotherapeutics. 2025 Apr;22(3):e00512. doi: 10.1016/j.neurot.2024.e00512. Epub 2025 Jan 3.
6
ablation attenuates pathological phenotypes in a mouse model of tauopathy.消融可减轻tau蛋白病小鼠模型中的病理表型。
Brain Commun. 2024 Apr 17;6(3):fcae136. doi: 10.1093/braincomms/fcae136. eCollection 2024.
7
The heat shock protein Hsp27 controls mitochondrial function by modulating ceramide generation.热休克蛋白 Hsp27 通过调节神经酰胺的产生来控制线粒体功能。
Cell Rep. 2023 Sep 26;42(9):113081. doi: 10.1016/j.celrep.2023.113081. Epub 2023 Sep 8.
8
Understanding chaperone specificity: evidence for a 'client code'.理解伴侣蛋白的特异性:“客户码”的证据。
Trends Biochem Sci. 2023 Aug;48(8):662-664. doi: 10.1016/j.tibs.2023.05.008. Epub 2023 Jun 15.
9
Concomitant protein pathogenesis in Parkinson's disease and perspective mechanisms.帕金森病中的伴随蛋白发病机制及潜在机制
Front Aging Neurosci. 2023 Apr 27;15:1189809. doi: 10.3389/fnagi.2023.1189809. eCollection 2023.
tau 修饰谱可识别患者异质性和阿尔茨海默病的阶段。
Cell. 2020 Dec 10;183(6):1699-1713.e13. doi: 10.1016/j.cell.2020.10.029. Epub 2020 Nov 13.
4
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer's disease.tau 分子多样性导致阿尔茨海默病的临床异质性。
Nat Med. 2020 Aug;26(8):1256-1263. doi: 10.1038/s41591-020-0938-9. Epub 2020 Jun 22.
5
Nicotinamide mononucleotide adenylyltransferase uses its NAD substrate-binding site to chaperone phosphorylated Tau.烟酰胺单核苷酸腺苷酰转移酶利用其 NAD 底物结合位点来伴侣磷酸化 Tau。
Elife. 2020 Apr 6;9:e51859. doi: 10.7554/eLife.51859.
6
Hsp27 chaperones FUS phase separation under the modulation of stress-induced phosphorylation.应激诱导磷酸化调控下 Hsp27 伴侣 FUS 相分离。
Nat Struct Mol Biol. 2020 Apr;27(4):363-372. doi: 10.1038/s41594-020-0399-3. Epub 2020 Mar 30.
7
Release of a disordered domain enhances HspB1 chaperone activity toward tau.无序结构域的释放增强了 HspB1 对 tau 的分子伴侣活性。
Proc Natl Acad Sci U S A. 2020 Feb 11;117(6):2923-2929. doi: 10.1073/pnas.1915099117. Epub 2020 Jan 23.
8
Nmnat restores neuronal integrity by neutralizing mutant Huntingtin aggregate-induced progressive toxicity.NMNAT 通过中和突变 Huntingtin 聚集诱导的进行性毒性来恢复神经元完整性。
Proc Natl Acad Sci U S A. 2019 Sep 17;116(38):19165-19175. doi: 10.1073/pnas.1904563116. Epub 2019 Sep 4.
9
Local unfolding of the HSP27 monomer regulates chaperone activity.局部展开 HSP27 单体调节伴侣活性。
Nat Commun. 2019 Mar 6;10(1):1068. doi: 10.1038/s41467-019-08557-8.
10
Highly specific and selective anti-pS396-tau antibody C10.2 targets seeding-competent tau.高度特异性和选择性的抗pS396- tau抗体C10.2靶向具有种子活性的tau。
Alzheimers Dement (N Y). 2018 Oct 14;4:521-534. doi: 10.1016/j.trci.2018.09.005. eCollection 2018.